Faeth Therapeutics FTH
NASDAQ FTH
$21.06 +0.49 (+2.38%)
As of: Oct 22, 2026 · 10:16 AM EDT

Faeth Therapeutics (FTH) Selling, General & Administrative (2020 - 2026)

Updated

Faeth Therapeutics (FTH) posted Selling, General & Administrative of $9.21 million for Q2 2026, up 244.4% from $2.67 million a year earlier but down 53.3% from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Faeth Therapeutics was $34.02 million, up 177.9% year-over-year; for FY2025, it was $11.33 million, down 13.1% from FY2024.

  • Annual Selling, General & Administrative has declined for three consecutive years, though with a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
  • In prior years, Faeth Therapeutics' Selling, General & Administrative was $13.04 million in FY2024 (-30.5%), $18.77 million in FY2023 (-5.3%), $19.81 million in FY2022 (+25.2%) and $15.82 million in FY2021 (+110.1%).
  • Quarterly Selling, General & Administrative has run from a low of $2.32 million in Q3 2025 to a high of $19.71 million in Q1 2026 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with growth averaging 75.8%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2026, with growth of 455.5%; the weakest was Q2 2024, with a decline of 40.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $19.71 million (Q1 2026), $2.79 million (Q4 2025) and $2.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn 6.43 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn 3.63 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn 1.92 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn 3.41 Bn
10 Faeth Therapeutics 118.85 Mn -316.61 Mn - 9.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.21 Mn
Mar 31, 2026 19.71 Mn
Dec 31, 2025 2.79 Mn
Sep 30, 2025 2.32 Mn
Jun 30, 2025 2.67 Mn
Mar 31, 2025 3.55 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 3.19 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 3.81 Mn
Dec 31, 2023 3.65 Mn
Sep 30, 2023 3.92 Mn
Jun 30, 2023 5.39 Mn
Mar 31, 2023 5.80 Mn
Dec 31, 2022 5.70 Mn
Sep 30, 2022 4.75 Mn
Jun 30, 2022 4.32 Mn
Mar 31, 2022 5.03 Mn
Dec 31, 2021 3.46 Mn
Sep 30, 2021 3.87 Mn
API Access

Faeth Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FTH&period=max&api_key=YOUR_API_KEY